SAN DIEGO: Aethlon Medical, Inc. has disclosed that it will provide Hemopurifier® therapy under FDA expanded access "emergency use" provisions to support requests from qualified physicians and institutes that may seek to treat ebola virus infection in the United States.
- John Aduma
- Health Security
- Posted On




